{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:07:45Z","timestamp":1762430865450,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejphar.2014.05.016","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:48:34Z","timestamp":1400719714000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats"],"prefix":"10.1016","volume":"737","author":[{"given":"Michael","family":"Feigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara T.","family":"Hjuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim V.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Gydesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Ottosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Erik","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Beck-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.05.016_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0030-1253395","article-title":"Streptozotocin causes pancreatic beta cell failure via early and sustained biochemical and cellular alterations","volume":"118","author":"Adeghate","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ejphar.2014.05.016_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","article-title":"Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets","volume":"111","author":"Akesson","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2014.05.016_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(93)81078-E","article-title":"Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin","volume":"325","author":"Albrandt","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2014.05.016_bib4","first-page":"R76","article-title":"Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys","volume":"295","author":"Bello","year":"2008","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2014.05.016_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-68-2-374","article-title":"Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies","volume":"68","author":"Bonora","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.05.016_bib6","first-page":"R1798","article-title":"Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats","volume":"293","author":"Chelikani","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2014.05.016_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity- modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.016_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1113\/jphysiol.2002.018671","article-title":"Salmon calcitonin \u2013 a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents","volume":"541","author":"Eiden","year":"2002","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.ejphar.2014.05.016_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/GME.0b013e31827c58ab","article-title":"Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats","volume":"20","author":"Feigh","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.ejphar.2014.05.016_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2012.01979.x","article-title":"Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats","volume":"167","author":"Feigh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.016_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1463-1326.2011.01425.x","article-title":"A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats","volume":"13","author":"Feigh","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2014.05.016_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0031-1298027","article-title":"Oral salmon calcitonin improves fasting and postprandial glycemic control in lean healthy rats","volume":"44","author":"Feigh","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2014.05.016_bib13","doi-asserted-by":"crossref","first-page":"E871","DOI":"10.1152\/ajpendo.00551.2006","article-title":"Thiazolidinediones improve beta-cell function in type 2 diabetic patients","volume":"292","author":"Gastaldelli","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.05.016_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000264394","article-title":"Roles of amylin in satiation, adiposity and brain development","volume":"63","author":"Lutz","year":"2010","journal-title":"Forum Nutr."},{"key":"10.1016\/j.ejphar.2014.05.016_bib16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2014.05.016_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0196-9781(99)00208-9","article-title":"Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)","volume":"21","author":"Lutz","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2014.05.016_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2014.05.016_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/diacare.21.5.687","article-title":"The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM","volume":"21","author":"Markovic","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.05.016_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/dmrr.263","article-title":"Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity","volume":"18","author":"Mather","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ejphar.2014.05.016_bib21","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.05.016_bib22","first-page":"1083","article-title":"Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus","volume":"81","author":"Nyholm","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.05.016_bib23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.peptides.2008.02.002","article-title":"Central and peripheral administration of amylin induces energy expenditure in anesthetized rats","volume":"29","author":"Osaka","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2014.05.016_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0091-3057(80)90196-3","article-title":"Calcitonin reduces feeding in man, monkey and rat","volume":"12","author":"Perlow","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.05.016_bib25","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2014.05.016_bib26","first-page":"203","article-title":"Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes","volume":"2","author":"Ryan","year":"2009","journal-title":"Drug Des. Dev.. Ther."},{"key":"10.1016\/j.ejphar.2014.05.016_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1476-5381.1996.tb15197.x","article-title":"Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: study in the perfused pancreas of the rat","volume":"117","author":"Silvestre","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.016_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2014.05.016_bib29","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(08)60932-0","article-title":"Type 2 diabetes: pathogenesis and treatment","volume":"371","author":"Stumvoll","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.05.016_bib30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control","volume":"7","author":"Weyer","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2014.05.016_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.physbeh.2007.02.012","article-title":"The acute effect of amylin and salmon calcitonin on energy expenditure","volume":"91","author":"Wielinga","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2014.05.016_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s001250050088","article-title":"Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans","volume":"37","author":"Wilding","year":"1994","journal-title":"Diabetologia"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:03:28Z","timestamp":1762142608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914003781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":31,"alternative-id":["S0014299914003781"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}